Stage 4 breast cancer means cancer that started in the breast has spread to other parts of the body. It is also called metastatic breast cancer. The most common places it spreads are the bones, lungs, liver, and brain. Unlike earlier stages, stage 4 is not typically curable, but treatments can control the disease for months or years, and many people live with it as a long-term condition.
About 6% of women are already at stage 4 when they first receive a breast cancer diagnosis. More commonly, stage 4 develops as a recurrence, meaning cancer that was treated earlier returns and appears in organs or tissues far from the original tumor.
How Stage 4 Differs From Earlier Stages
In stages 1 through 3, breast cancer is confined to the breast and nearby lymph nodes. Treatment at those stages aims for a cure. Stage 4 changes the picture because cancer cells have traveled through the bloodstream or lymphatic system to establish new tumors in distant organs. These distant tumors are still breast cancer cells, not a new cancer of the lung or liver, and they respond to breast cancer treatments.
The shift from “curable” to “treatable” is the defining line between stage 3 and stage 4. That doesn’t mean treatment stops. It means the goal becomes controlling the disease, shrinking tumors, relieving symptoms, and extending life with the best quality possible.
Where It Spreads and What That Feels Like
The symptoms of stage 4 breast cancer depend almost entirely on where the cancer has traveled. Some people have no noticeable symptoms at first and learn about the spread through routine scans. Others notice new problems that prompt further testing.
- Bones: The most common site. Bone metastases cause deep, persistent pain that worsens over time and can lead to fractures in weakened areas.
- Lungs: Shortness of breath, a chronic cough, or chest pain that doesn’t resolve.
- Liver: Swelling in the abdomen, yellowing of the skin or eyes (jaundice), nausea, or loss of appetite.
- Brain: Headaches, dizziness, seizures, or changes in vision and speech.
These symptoms overlap with many other conditions, which is why imaging and biopsies are needed to confirm the spread.
How It Is Diagnosed
If you have symptoms that suggest cancer may have spread, or if breast cancer has been newly diagnosed or has returned, doctors use a combination of imaging tools to check the rest of your body. The initial workup often includes a chest X-ray, a bone scan, an ultrasound of the liver, and a CT scan.
When those tests find something abnormal or the results aren’t clear, more detailed imaging follows. MRI provides higher-resolution views of specific areas, and PET/CT scans can detect active cancer throughout the body in a single session. Doctors may also biopsy a suspicious spot in a distant organ to confirm the cells are breast cancer and to test their molecular profile, which directly shapes treatment decisions.
Why Your Cancer’s Subtype Matters
Not all breast cancers behave the same way, and at stage 4, the tumor’s biology becomes even more important than the stage number alone. Doctors test the cancer for hormone receptors (estrogen and progesterone) and a protein called HER2. These results place the cancer into subtypes that respond to different treatments.
Hormone receptor-positive cancers, the most common subtype, can be treated with hormone-blocking therapies that slow or stop growth. Research shows that people whose tumors test positive for the progesterone receptor specifically tend to have better outcomes, and those who respond well to their first round of hormone therapy survive significantly longer. If a first hormone therapy stops working, switching to a second can still provide meaningful benefit, with median survival times of roughly 45 months for responders compared to about 26 months for non-responders.
HER2-positive cancers are treated with targeted drugs that block the HER2 protein. This subtype once carried a poor prognosis, but newer targeted therapies have dramatically improved outcomes. Triple-negative breast cancer, which lacks hormone receptors and HER2, has fewer targeted options but may respond to immunotherapy and chemotherapy.
Treatment Approaches
Stage 4 breast cancer is treated with systemic therapies, meaning drugs that reach cancer cells throughout the body. The main categories are hormone therapy, chemotherapy, targeted therapy, and immunotherapy. Which combination you receive depends on your cancer’s subtype, where it has spread, how fast it’s growing, and how you’ve responded to previous treatments.
Hormone therapy is the backbone for hormone receptor-positive cancers and works by starving tumor cells of the signals they need to grow. Targeted therapies zero in on specific proteins that fuel cancer growth. Chemotherapy attacks rapidly dividing cells more broadly and is used when faster-growing cancers need an aggressive response or when targeted options have been exhausted. Immunotherapy, which helps your immune system recognize and attack cancer cells, is currently used primarily for triple-negative breast cancer.
Treatment at stage 4 is ongoing. You may stay on one regimen for months or years until the cancer adapts, then switch to a different approach. The goal is always to use the most effective therapy with the fewest side effects, keeping the disease controlled while preserving your daily life as much as possible.
Living With Stage 4 as a Chronic Condition
Oncologists increasingly describe metastatic breast cancer as a chronic disease, similar in some ways to conditions like diabetes or heart failure. It requires long-term treatment, regular monitoring, and adjustments over time, but many people live with it for years. The five-year relative survival rate for distant-stage breast cancer is 32.6%, based on data from 2015 through 2021, and that number continues to improve as new treatments become available.
Living with a chronic cancer means balancing disease control with quality of life. Doctors aim for therapies with limited cumulative toxicity so the treatment itself doesn’t become harder to bear than the disease. Regular scans track how well the cancer is responding, and treatment plans evolve as new options emerge or the cancer changes.
The emotional weight of a stage 4 diagnosis is real. Honest, ongoing conversations with your medical team about your values, preferences, and goals are a critical part of care. What you want your daily life to look like matters as much as what shows up on a scan.
The Role of Palliative Care
Palliative care is often misunderstood as something reserved for the end of life. In stage 4 breast cancer, it can start at diagnosis and run alongside active cancer treatment. Its purpose is to manage symptoms, control pain, and address the emotional and psychological toll of living with advanced cancer.
Pain management is a core focus, especially for bone metastases. Palliative care teams also help with fatigue, nausea, sleep problems, and the anxiety or depression that commonly accompany a metastatic diagnosis. This includes both medication-based approaches and non-pharmacologic strategies like counseling, peer support groups, and spiritual care.
Palliative care is distinct from hospice. Hospice typically begins when active cancer treatment has been stopped and the focus shifts entirely to comfort. Palliative care has no such restriction. You can receive chemotherapy, targeted therapy, and palliative care all at the same time. Research supports this combined approach as a way to maintain a reasonable quality of life even during intensive treatment.